Akero Therapeutics 株価情報 (NASDAQ: AKRO)

最新ニュース Akero Therapeutics (NASDAQ:AKRO) 株価情報

Akero Therapeutics

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Akero Therapeutics Inc

Akropolis

Outlook
<ul>
<li>Strong sulfur nutrition demand and tight North American ammonium sulfate supply expected to support sulfur premiums at or near high end of historical range; Anticipated higher raw material prices impacting fertilizer margins</li>
<li>Balanced global acetone supply and demand conditions expected to support industry spreads above cycle averages</li>
<li>Expect slower recovery off the trough for North American nylon industry conditions amid stable end market demand and increased domestic competitive pressure</li>
<li>Expect Capital Expenditures of $140 to $160 million in 2025, reflecting the planned progression of growth projects including our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program, and refined execution timing to address critical enterprise risk mitigation</li>
<li>Expect pre-tax income impact of plant turnarounds to be $25 to $30 million in 2025 versus approximately $58 million in 2024</li>
<li>Final omnibus settlement of approximately $26 million in 1Q25 related to PES supplier shutdown; Total of approximately $39 million aggregated insurance proceeds since 2019 event</li>
</ul>

Earnings

News

Guidance

ASIX

AdvanSix Projects $140M-$160M In 2025 Capital Expenditures And Anticipates $25M-$30M Pre-Tax Impact From Plant Turnarounds

Barclays analyst Jiong Shao maintains Alibaba Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) with a Overweight and raises the price target from $130 to $180.

Price Target

Analyst Ratings

BABA

Barclays Maintains Overweight on Alibaba Gr Hldgs, Raises Price Target to $180

TXNM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.32 by 6.25 percent. This is a 66.67 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $476.96 million which missed the analyst consensus estimate of $546.36 million by 12.70 percent. This is a 15.74 percent increase over sales of $412.11 million the same period last year.

Earnings Misses

TXNM

TXNM Energy Q4 Adj $0.30 Misses $0.32 Estimate, Sales $476.96M Miss $546.36M Estimate

Barclays analyst Ryan Macwilliams maintains RingCentral (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) with a Equal-Weight and lowers the price target from $37 to $31.

Barclays Maintains Equal-Weight on RingCentral, Lowers Price Target to $31

As disclosed in the paper, 4 out of 4 young children with the AIPL1-related retinal dystrophy, LCA4, benefited substantially from unilateral subretinal administration of rAAV8.hRKp.AIPL1 with improved visual acuity, functional vision, and protection against progressive retinal degeneration, the company said.

MGTX

MeiraGTx Reports Publication Of Results From First-in-human Interventional Study To Treat Children With AIPL1-Associated Severe Retinal Dystrophy

AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.38) by 123.68 percent. This is a 190 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $329.063 million which missed the analyst consensus estimate of $374.000 million by 12.02 percent. This is a 13.90 percent decrease over sales of $382.208 million the same period last year.

Earnings Beats

AdvanSix Q4 2024 Adj. EPS $0.09 Beats $(0.38) Estimate, Sales $329.063M Miss $374.000M Estimate

Needham analyst Mayank Tandon maintains Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Buy and lowers the price target from $43 to $38.

DAVA

Needham Maintains Buy on Endava, Lowers Price Target to $38

Barclays analyst Ryan Macwilliams maintains Bandwidth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) with a Overweight and lowers the price target from $25 to $22.

BAND

Barclays Maintains Overweight on Bandwidth, Lowers Price Target to $22

Needham analyst Ryan MacDonald reiterates Talkspace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>) from Hold to Hold.

Reiteration

TALK

Needham Reiterates Hold on Talkspaceto Hold

Needham analyst Scott Berg maintains BigCommerce Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIGC#NASDAQ">BIGC</a>) with a Buy and maintains $10 price target.

BIGC

Needham Maintains Buy on BigCommerce Holdings, Maintains $10 Price Target

Telsey Advisory Group analyst Joseph Feldman maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and maintains $115 price target.

Telsey Advisory Group Maintains Outperform on Walmart, Maintains $115 Price Target

On Thursday, February 20, U.S. markets closed lower as investor confidence weakened due to growing tariff concerns and Walmart&#8217;s disappointing <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street" rel="noreferrer noopener">sales and profit outlook</a>. All major indexes declined, with the Dow experiencing the steepest drop, while the S&amp;P 500 ended its streak of record highs. Gold prices surged to a historic peak as investors sought safer assets amid rising economic uncertainty. Walmart&#8217;s weaker forecast signaled potential declines in consumer spending, amplifying worries about economic growth.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/market-summary/25/02/43875446/walmarts-ai-use-cases-surge-amid-strong-q4-even-as-company-forecasts-weaker-2026" rel="noreferrer noopener">Walmart Expands AI Use Beyond Optimizing Delivery Routes, To Tackling Inventory Issues And Delivering Code Faster</a>
In economic data, initial jobless claims rose by 5,000 to 219,000 for the week ending February 15, slightly above the expected 215,000. The Philadelphia Fed Manufacturing Index fell sharply to 18.1 in February from 44.3 the prior month.
Most S&amp;P 500 sectors declined, led by financial, consumer discretionary, and consumer staples, while energy and real estate stocks closed higher.
The Dow Jones Industrial Average declined 1.01% to close at 44,176.65, while the S&amp;P 500 slid 0.43% to 6,117.52. The Nasdaq Composite fell 0.47%, finishing at 19,962.36.
Asia Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 rose 0.28% to close at 38,784.00, led by gains in the Gas and water, Transport, and Marine Transport sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 declined 0.32% to 8,296.20, led by losses in the Consumer Discretionary, Telecoms Services and Financials sectors.</li>
<li>India&#8217;s Nifty 50 slipped 0.65% to 22,763.95, and the Nifty 500 declined 0.84% to close at 20,656.30, led by losses in the Auto, Oil &amp; Gas, and Real Estate sectors.</li>
<li>China&#8217;s Shanghai Composite rose 0.85% to 3,379.11, and the Shanghai Shenzhen CSI 300 gained 1.26%, ending at 3,978.44.</li>
<li>Hong Kong&#8217;s Hang Seng surged 3.99% to close at 23,477.92.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was up 0.33%.</li>
<li>Germany&#8217;s DAX gained 0.03%.</li>
<li>France&#8217;s CAC rose 0.47%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.10%</li>
<li>European shares rose Friday as investors assessed economic data and Germany&#8217;s upcoming election. The STOXX 600 rebounded but eyed weekly losses.</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 1.06% at $71.71/bbl, and Brent was down 1.02% at $75.71/bbl.</li>
<li>Oil prices dipped Friday but remained on track for weekly gains amid supply concerns in Russia and rising demand in the U.S. and China. The market focus stayed on supply disruptions and geopolitical tensions.</li>
<li>Natural Gas gained 3.95% to $4.316.</li>
<li>Gold was trading lower by 0.38% at $2,944.99, Silver was down 0.47% to $33.325, and Copper fell 0.89% to $4.5713.       </li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures were up 0.11%, S&amp;P 500 futures gained 0.02%, and Nasdaq 100 futures rose 0.11%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. dollar index gained 0.29% to 106.67, the USD/JPY rose 0.45% to 150.38, and the USD/AUD rose 0.21% to 1.5656.</li>
<li>The dollar headed for a third weekly drop as Trump&#8217;s tariff threats remained largely rhetoric, while the yen surged on rising Japanese inflation before the BOJ intervened.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Rebounds; Dollar Heads For Third Weekly Drop - Global Markets Today While US Slept

Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) disclosed that its subsidiary, FF China, shipped two FX 6&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43874924/faraday-future-announces-the-shipment-of-its-first-two-fx-6-camouflaged-prototype-mules-to-the-u-s" rel="noreferrer noopener">camouflaged prototype mules to customs</a>.&nbsp;
These vehicles are now en route to the&nbsp;company&#8217;s&nbsp;U.S. headquarters in Los Angeles, marking a significant step in their development process.
The FX 6, part of Faraday&nbsp;Future&#8217;s&nbsp;FX lineup, aims to bring Advanced Intelligent Electric Vehicles (AIEVs) to the mass market.&nbsp;
The camouflaged prototypes will undergo rigorous U.S. testing to ensure top-tier performance, technology, and user experience.
Once in Los Angeles, evaluations will focus on ADAS and autonomous driving validation, powertrain optimization, and intelligent cabin enhancements.
The FX brand will cater to the mass market with three planned models: the AI-MPV Super One, the FX 5 ($20,000-$30,000), and the FX 6 ($30,000-$50,000).
Faraday Future will share more updates on the FX 6 series and its broader FX strategy in March.
This week, the company disclosed that it began recruiting AI specialists, particularly in large-model development and algorithm training, to&nbsp;<a target="_blank" href="https://www.benzinga.com/news/small-cap/25/02/43809777/faraday-future-goes-all-in-on-ai-new-hires-open-ai-day-and-more" rel="noreferrer noopener">accelerate&nbsp;its AI R&amp;D expansion</a>.&nbsp;
Price Action: FFIE shares are up 2.71% at $1.705 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43874096" target="_blank" rel="noreferrer noopener">Gary Black Left Unimpressed By Rivian&#8217;s Earnings : Calls 2025 Guidance &#8216;Clearly Weak&#8217;</a></li>
</ul>
Photo: T. Schneider via Shutterstock.

Equities

Small Cap

FFIE

Faraday Future's FX 6 Prototypes Head To Los Angeles For US Testing

SpaceX CEO Elon Musk on Thursday alleged that the return of the astronauts who went to the International Space Station (ISS) aboard Boeing Co.&#8217;s Starliner spacecraft last year &#8211; Sunita Williams and Butch Wilmore &#8211; was delayed owing to &#8220;political reasons.&#8221;
What Happened: &#8220;SpaceX could have brought the astronauts back last year, but Biden pushed the return past the inauguration date,&#8221; Musk said in a post on social media platform X. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This Community Note is false. SpaceX could have brought the astronauts back last year, but Biden pushed the return past the inauguration date. Legacy media is NOT a reliable source.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1892582468911296664?ref_src=twsrc%5Etfw">February 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk alleged that the administration did not discuss the price of the mission when he offered to return the astronauts several months ago but flatly refused.
&#8220;We would have made it work within the annual budget. The real issue is that they did not want positive press for someone who supported Trump,&#8221; Musk, a Trump-ally, said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Price was never even discussed! They flatly refused. We would have made it work within the annual budget. The real issue is that they did not want positive press for someone who supported Trump. That's it. End of story.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1892617681796264436?ref_src=twsrc%5Etfw">February 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
ESA astronaut Andreas Mogensen, who was part of SpaceX&#8217;s crew-7 mission, alleged that Musk&#8217;s claim was a lie, leading to a heated exchange between the billionaire and the astronaut.
&#8220;You know as well as I do, that Butch and Suni are returning with Crew-9, as has been the plan since last September. Even now, you are not sending up a rescue ship to bring them home. They are returning on the Dragon capsule that has been on ISS since last September,&#8221; Mogensen said.
Musk, however, resorted to name-calling and said that Mogensen has &#8220;no clue what&#8217;s really going on.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon, I have long admired you and what you have accomplished, especially at SpaceX and Tesla. You know as well as I do, that Butch and Suni are returning with Crew-9, as has been the plan since last September. Even now, you are not sending up a rescue ship to bring them home.…
&mdash; Andreas Mogensen (@Astro_Andreas) <a href="https://twitter.com/Astro_Andreas/status/1892588041908207773?ref_src=twsrc%5Etfw">February 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Return Of Starliner Astronauts: Williams and Wilmore launched to the International Space Station aboard Starliner&nbsp;spacecraft in June and were supposed to return in about eight days.
However, technical issues identified with the spacecraft while docking delayed a return, and the space agency subsequently decided to scrap bringing back the two astronauts on the Starliner spacecraft. 
The Starliner subsequently<a href="https://www.benzinga.com/news/24/09/40758526/boeing-starliner-returns-to-earth-without-sunita-williams-and-butch-wilmore-lands-in-new-mexico-afte" target="_blank" rel="noreferrer noopener">&nbsp;returned without the astronauts on Sept. 6</a>. The two astronauts, NASA then said, will return with Crew 9 members&nbsp;Nick Hague&nbsp;and&nbsp;Aleksandr Gorbunov&nbsp;<a href="https://www.benzinga.com/news/24/09/40850262/nasa-delays-crew-9-mission-yet-again-this-time-to-complete-prelaunch-preparations" target="_blank" rel="noreferrer noopener">when they return home</a>&nbsp;aboard a SpaceX Dragon spacecraft.
NASA said earlier this month that it intends to return Williams and Wilmore earlier than previously expected.
The space agency said that it is now targeting Wednesday, March 12 for the launch of its Crew-10 mission to the space station.
Following a few days' handover period where crew-9 astronauts will familiarize the newly arrived crew-10 with ongoing science and station maintenance work, crew-9 will return to Earth with Hague, Williams, Wilmore, and Gorbunov aboard SpaceX's Dragon spacecraft.
The return of crew-9, however, will also rely on weather conditions at the dragon spacecraft's splashdown site off the coast of Florida, NASA said.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/25/02/43874743/elon-musks-spacex-starships-8th-test-flight-could-launch-as-early-as-feb-26" target="_blank" rel="noreferrer noopener">Elon Musk-Led SpaceX Likely To Undertake Starship's 8th Test Flight On Feb 26: Here's What We Know</a></li>
</ul>
Photo courtesy: NASA

SPACE

Tech

SpaceX CEO Elon Musk Pegs Delay In Returning Sunita Williams And Butch Wilmore From Space Station To 'Political Reasons'

Telsey Advisory Group analyst Dana Telsey maintains Clear Secure (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOU#NYSE">YOU</a>) with a Outperform and maintains $42 price target.

Telsey Advisory Group Maintains Outperform on Clear Secure, Maintains $42 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Birkenstock Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) with a Outperform and maintains $70 price target.

BIRK

Telsey Advisory Group Maintains Outperform on Birkenstock Holding, Maintains $70 Price Target

Telsey Advisory Group analyst Joseph Feldman maintains Floor &amp; Decor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>) with a Outperform and maintains $115 price target.

Telsey Advisory Group Maintains Outperform on Floor & Decor Hldgs, Maintains $115 Price Target

IAUX

I-80 Gold Corp. Reveals Results Of The Preliminary Economic Assessment For The Mineral Point Project: Says EA Demonstrates That Mineral Point Has Potential To Become Flagship Asset Within Company's Gold Portfolio

The partnership has resulted in the launch of their first collaborative product, the "Parent-Child Learning Big Screen," which officially went on sale on February 20th.

NAMI

Jinxin's Namibox Enters Strategic Partnership With Hisense Group

Nano Labs Reveals Pricing Of Unregistered Sale Of Equity Securities And Increased Bitcoin Holdings To 400

Press Releases

Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference

Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Health Care

Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD

Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm

Legal

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

General

Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASH—by Both Completer and ITT Analyses—at Week 96 in Phase 2b SYMMETRY Study

Financing

Akero Therapeutics Announces Proposed Public Offering of Common Stock

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Akero Therapeutics, Inc. (NASDAQ: AKRO); Crocs, Inc. (NASDAQ: CROX); Extreme Networks, Inc. (NASDAQ: EXTR); and Domino's Pizza Corp. (NASDAQ: DPZ)

Comments

Akero Therapeutics

ニュース

最新ニュース Akero Therapeutics (NASDAQ:AKRO) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル